vs
McEwen Inc.（MUX）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是McEwen Inc.的1.2倍（$75.5M vs $64.6M），McEwen Inc.同比增速更快（92.8% vs 27.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 25.2%）
McEwen Inc（股票代码MUX）是一家自然资源企业，主要从事金、银、铜矿产的勘探、开发与生产业务，运营项目分布于南北美洲，秉持可持续负责任的采矿准则，产品面向全球大宗商品市场供应。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MUX vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$64.6M
营收增速更快
MUX
高出65.1%
27.7%
两年增速更快
PBYI
近两年复合增速
25.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $64.6M | $75.5M |
| 净利润 | $38.1M | — |
| 毛利率 | 26.9% | 69.3% |
| 营业利润率 | 34.2% | 22.7% |
| 净利率 | 59.0% | — |
| 营收同比 | 92.8% | 27.7% |
| 净利润同比 | 563.1% | — |
| 每股收益（稀释后） | $0.66 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MUXPBYI
| Q4 25 | $64.6M | $75.5M | ||
| Q3 25 | $50.5M | $54.5M | ||
| Q2 25 | $46.7M | $52.4M | ||
| Q1 25 | $35.7M | $46.0M | ||
| Q4 24 | $33.5M | $59.1M | ||
| Q3 24 | $52.3M | $80.5M | ||
| Q2 24 | $47.5M | $47.1M | ||
| Q1 24 | $41.2M | $43.8M |
净利润MUXPBYI
| Q4 25 | $38.1M | — | ||
| Q3 25 | $-462.0K | $8.8M | ||
| Q2 25 | $3.0M | $5.9M | ||
| Q1 25 | $-6.3M | $3.0M | ||
| Q4 24 | $-8.2M | — | ||
| Q3 24 | $-2.1M | $20.3M | ||
| Q2 24 | $-13.0M | $-4.5M | ||
| Q1 24 | $-20.4M | $-4.8M |
毛利率MUXPBYI
| Q4 25 | 26.9% | 69.3% | ||
| Q3 25 | 15.5% | 77.7% | ||
| Q2 25 | 26.3% | 76.5% | ||
| Q1 25 | 28.2% | 77.1% | ||
| Q4 24 | 1.1% | 76.4% | ||
| Q3 24 | 26.4% | 63.9% | ||
| Q2 24 | 22.7% | 77.4% | ||
| Q1 24 | 14.6% | 75.5% |
营业利润率MUXPBYI
| Q4 25 | 34.2% | 22.7% | ||
| Q3 25 | -16.7% | 17.6% | ||
| Q2 25 | -7.2% | 12.7% | ||
| Q1 25 | -21.4% | 8.7% | ||
| Q4 24 | -43.4% | 22.6% | ||
| Q3 24 | -0.2% | 27.4% | ||
| Q2 24 | -29.4% | -4.6% | ||
| Q1 24 | -53.3% | -5.3% |
净利率MUXPBYI
| Q4 25 | 59.0% | — | ||
| Q3 25 | -0.9% | 16.2% | ||
| Q2 25 | 6.5% | 11.2% | ||
| Q1 25 | -17.6% | 6.5% | ||
| Q4 24 | -24.6% | — | ||
| Q3 24 | -4.0% | 25.2% | ||
| Q2 24 | -27.4% | -9.6% | ||
| Q1 24 | -49.4% | -11.0% |
每股收益（稀释后）MUXPBYI
| Q4 25 | $0.66 | $0.26 | ||
| Q3 25 | $-0.01 | $0.17 | ||
| Q2 25 | $0.06 | $0.12 | ||
| Q1 25 | $-0.12 | $0.06 | ||
| Q4 24 | $-0.15 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $-0.26 | $-0.09 | ||
| Q1 24 | $-0.41 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.1M | $97.5M |
| 总债务越低越好 | $126.2M | $22.7M |
| 股东权益账面价值 | $546.2M | $130.3M |
| 总资产 | $820.2M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.23× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MUXPBYI
| Q4 25 | $72.1M | $97.5M | ||
| Q3 25 | $75.4M | $94.4M | ||
| Q2 25 | $69.5M | $96.0M | ||
| Q1 25 | $79.3M | $93.2M | ||
| Q4 24 | $15.3M | $101.0M | ||
| Q3 24 | $30.2M | $96.7M | ||
| Q2 24 | $42.6M | $96.8M | ||
| Q1 24 | $22.0M | $107.2M |
总债务MUXPBYI
| Q4 25 | $126.2M | $22.7M | ||
| Q3 25 | $126.0M | $34.0M | ||
| Q2 25 | $125.8M | $45.3M | ||
| Q1 25 | $125.5M | $56.7M | ||
| Q4 24 | $40.0M | $68.0M | ||
| Q3 24 | $31.0M | $79.3M | ||
| Q2 24 | $34.0M | $90.7M | ||
| Q1 24 | $37.0M | $102.0M |
股东权益MUXPBYI
| Q4 25 | $546.2M | $130.3M | ||
| Q3 25 | $488.6M | $115.3M | ||
| Q2 25 | $484.5M | $104.7M | ||
| Q1 25 | $479.8M | $97.1M | ||
| Q4 24 | $495.0M | $92.1M | ||
| Q3 24 | $502.1M | $71.1M | ||
| Q2 24 | $485.2M | $48.5M | ||
| Q1 24 | $482.5M | $51.0M |
总资产MUXPBYI
| Q4 25 | $820.2M | $216.3M | ||
| Q3 25 | $747.6M | $202.9M | ||
| Q2 25 | $735.6M | $194.9M | ||
| Q1 25 | $730.6M | $196.2M | ||
| Q4 24 | $664.6M | $213.3M | ||
| Q3 24 | $667.8M | $220.7M | ||
| Q2 24 | $645.1M | $205.0M | ||
| Q1 24 | $638.7M | $214.1M |
负债/权益比MUXPBYI
| Q4 25 | 0.23× | 0.17× | ||
| Q3 25 | 0.26× | 0.30× | ||
| Q2 25 | 0.26× | 0.43× | ||
| Q1 25 | 0.26× | 0.58× | ||
| Q4 24 | 0.08× | 0.74× | ||
| Q3 24 | 0.06× | 1.12× | ||
| Q2 24 | 0.07× | 1.87× | ||
| Q1 24 | 0.08× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 0.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流MUXPBYI
| Q4 25 | $3.1M | $14.4M | ||
| Q3 25 | $5.2M | $9.7M | ||
| Q2 25 | $478.0K | $14.1M | ||
| Q1 25 | $-1.9M | $3.6M | ||
| Q4 24 | $-1.2M | $15.6M | ||
| Q3 24 | $23.2M | $11.0M | ||
| Q2 24 | $3.6M | $1.0M | ||
| Q1 24 | $3.9M | $11.2M |
自由现金流MUXPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率MUXPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度MUXPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率MUXPBYI
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 0.16× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
